Combination Nicotine Replacement Therapy, Cytisine, or Varenicline for Smoking Cessation
Status:
RECRUITING
Trial end date:
2026-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to test whether clients of Sun Life are willing to join in a quit smoking program that offers counselling and tobacco cessation products to all participants over a 12-month period. The study team will track the safety and usage of 3 types of cessation products as well as the effectiveness of a virtual pharmacy (i.e. cessation products delivered to participants directly from a pharmacy) over a 12-week treatment period.
The purpose of this study is to look at 3 approved smoking cessation products used in combination with counselling and virtual delivery of the smoking cessation products. The goal is to track product usage, safety, and adherence (how much of the products people use and how many counselling sessions they complete).
Within the study there will also be an observational group who will not receive study medication but who will receive free virtual coaching and follow-up for smoking cessation and complete study questionnaires.
Phase:
PHASE4
Details
Lead Sponsor:
Ottawa Heart Institute Research Corporation
Collaborators:
Lumino Health Pharmacy Sun Life Assurance Company of Canada Vita Aid Professional Therapeutics
Treatments:
cytisine Nicotine Replacement Therapy Tobacco Use Cessation Devices Varenicline